Prashant Sakharkar

Asso Prof@COPharmacy, Roosevelt University, Educator & Health Outcomes Researcher & Life Long Learner

[Journal of the American Pharmacists Association @JAPhAJournal]

#TwitteRx Find these & other articles in the Sept/Oct issue!
+Meta-analysis of the CV toxicity of cannabinoids
+Addressing #SDOH in #communitypharmacy
+Discrimination & harassment in #pharmacy
+#PharmacyTechs roles in immunizations & product verification
https://t.co/R22cMONueP

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Polypharmacy, concomitant use of 5 or more medications, sometimes lead to suboptimal clinical outcomes in various disease states. We reviewed the impact of Polypharmacy on COVID-19 clinical outcomes.
#TwitteRx #pharmacists

https://t.co/w4tnHAVfnx

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: This study described current pharmacists’ and pharmacist extenders’ participation in emergency response activities and training, and their willingness to respond in any emergency situations.
#communitypharmacy #TwitteRx #pharmacists
https://t.co/SbSkFIpk80

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Socialized &Traumatized: Pharmacists, Underserved Patients, & the COVID-19 Vaccine. @NphaPharmacy describes minoritized Pharmacists & healthcare professionals' serving those affected by COVID-19.
#publichealth #TwitteRx #pharmacists
https://t.co/P69Iu6kcza

[Journal of the American Pharmacists Association @JAPhAJournal]

The July/Aug issue is out! A sample of topics you can find:
~healthcare #advocacy
~expanded #pharmacytechnician roles
~#opioid and #MedicalCannabis
monitoring programs
~#spirituality in practice
~care of #LGBTQIA individuals

Check it out now #TwitteRx: https://t.co/Ok91rzhRvg

[Journal of the American Pharmacists Association @JAPhAJournal]

We are excited to announce a call for papers in the area of #vaccine confidence and hesitancy. General author guidelines are at https://t.co/gu3aChG2LN. Submit your papers at https://t.co/mGO79AjnK8 Looking forward to some great submissions in this important area!

[Journal of the American Pharmacists Association @JAPhAJournal]

Check out the May/June issue! Some great articles on #pharmacists interventions in children w/ #asthma, economic burden of the #opioid crisis, technicians as immunizers, #endoflife medication counseling, hospital-in-home models w/ pharmacists, and more!
https://t.co/6wapRYhWuj

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Evaluated via a cluster randomized design across a national pharmacy network, peer comparisons were shown to significantly improve influenza vaccine uptake in community pharmacies by up to 6.1%

#quality #communitypharmacy #TwitteRx #pharmacists

https://t.co/yPkJiNpswv

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Medication nonadherence is associated with significant health care costs and morbidity. Reimbursement to pharmacists to support med sync programs is associated with significant improvement in adherence.

#communitypharmacy #TwitteRx #pharmacists
https://t.co/Es8QjhAA7R

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Pharmacists’ interventions may improve health outcomes in children. However, the number of studies in this subject is still low and showing low-quality evidence.
#pediatrics #TwitteRx #pharmacists

https://t.co/Wpp211ZO0J
[image]

[Journal of the American Pharmacists Association @JAPhAJournal]

Our first issue of 2021 has exciting papers on reimbursement for pharmacist services, #PrEP screening, and more! Also, check out the 2 sets of themed papers on culturally-appropriate care and med safety. #TwitteRx #CulturallyAppropriateCare #MedSafety
https://t.co/K8GjfKrqs2

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Active engagement of pharmacists in SARS-CoV-2 testing can help to address many of the gaps in testing availability and demonstrate the value that pharmacists can provide in addressing unmet health needs. #COVID19 #pharmacists

https://t.co/R9gK1OUxCM

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Pharmacists are the most accessible and essential health care providers willing to take on critically important roles during the COVID-19 pandemic provided appropriate safety measures can be met.
#COVID19 #publichealth #pharmacists #TwitteRx

https://t.co/SDhSkv1Dmx

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Actively combating misinformation as a pharmacist is a professional responsibility.
#COVID19 #publichealth #patienteducation #pharmacists #TwitteRx

https://t.co/pmUyMtiEnA

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: : The Board sought to update professional practice standards by transitioning from prescriptive regulations to a “standard of care” model that harmonizes pharmacists education and training with their legal scope of practice. #Idaho #pharmacists

https://t.co/DhIEkSAMY1

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: #Pharmacists are designated by #CDC as qualified and authorized immunizers, and thus there should be no additional barriers in place to require further authorizations or approvals under shared clinical decision making. #immunizations

https://t.co/pN79O3PUwV

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Shared decision-making for vaccines presents additional opportunities for #pharmacists and student pharmacists to actively engage patients in determining what vaccines they need and which
ones to consider. #vaccination

https://t.co/FLwlHESHc8

[Prashant Sakharkar @SPrashantPharmD]

Pharmacist experiences and perspectives with Oregon’s Death with Dignity Act https://t.co/cX5UYs4x1i

[Prashant Sakharkar @SPrashantPharmD]

Read to learn more about utilization of a psychiatric pharmacist in primary care setting as a viable model for the treatment of depression.

[Journal of the American Pharmacists Association @JAPhAJournal]

IN PRESS: Incorporation of a psychiatric #pharmacist into primary care can produce positive outcomes and improve access to #depression treatment. Patients maintained reduced PHQ-9 scores and were seen in less than one-third the time versus the BHC.

https://t.co/lhUmDU4S9N

[Prashant Sakharkar @SPrashantPharmD]

#HealthResearch Learn more about psychometrically sound scale to measure ADL in RA patients at #AACPVPS2020, #HealthResearch, https://t.co/R4p4oBJzKp @ACCP